Praveen P. Govender, MB BCh

Assistant Professor, Medicine

Praveen Govender
72 E. Concord St Housman (R)

Biography

Dr. Praveen Govender is the Associate Director of the Sarcoidosis Center with training in Pulmonary Medicine, Allergy and Immunology. He has worked extensively with Dr. Jeffrey Berman in the care of patients with sarcoidosis since 2008 at The Sarcoidosis Center at Boston Medical Center. Their mission is to improve the lives of persons with sarcoidosis by providing state-of-the-art patient care coupled with innovative research aimed at understanding the pathogenesis and natural history of sarcoidosis. Dr. Govender is an active member of the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG).

Other Positions

  • Member, Pulmonary Center, Boston University

Education

  • Royal College of Surgeons in Ireland, MBBCh
  • University of Alberta, BS

Publications

  • Published on 11/9/2024

    Sangani R, Bosch NA, Govender P, Scarpato B, Walkey AJ, Newman J, Law AC, Gillmeyer KR, Shankar DA. Sarcoidosis Treatment Patterns in the United States: 2016-2022. Chest. 2024 Nov 09. PMID: 39522595.

    Read at: PubMed
  • Published on 6/6/2023

    Halpin M, Lerner A, Sagar M, Govender P, Shah B, Weinberg J, Sarosiek S, Sloan JM. A prospective, single-center, randomized phase 2 trial of etoposide in severe COVID-19. medRxiv. 2023 Jun 06. PMID: 37333402.

    Read at: PubMed
  • Published on 11/1/2022

    Cozier YC, Govender P, Berman JS. Obesity and Sarcoidosis Risk: An Index Under Suspicion. Chest. 2022 Nov; 162(5):954-956. PMID: 36344120.

    Read at: PubMed
  • Published on 2/22/2021

    Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med. 2022 Apr; 37(4):441-458. PMID: 33611981.

    Read at: PubMed
  • Published on 10/1/2020

    Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473. PMID: 31309727.

    Read at: PubMed
  • Published on 9/3/2020

    Govender P, Cozier YC. Sarcoidosis in a time of pandemic. Eur Respir J. 2020 09; 56(3). PMID: 32883761.

    Read at: PubMed
  • Published on 6/30/2020

    Abston E, Moll M, Hon S, Govender P, Berman J, Farber H. Long-term outcomes of epoprostenol therapy in sarcoid associated pulmonary hypertension. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):184-191. PMID: 33093782.

    Read at: PubMed
  • Published on 6/30/2020

    Abston E, Hon S, Lawrence R, Berman J, Govender P, Farber HW. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):234-238. PMID: 33093789.

    Read at: PubMed
  • Published on 6/30/2020

    Nitzberg M, Parikh R, Govender P, Farber HW. Pulmonary hypertension secondary to takayasu's arteritis: management using a combined medical and interventional approach. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 37(2):239-241. PMID: 33093790.

    Read at: PubMed
  • Published on 4/15/2020

    Cozier YC, Govender P. Sarcoidosis: An Ill-afforded Disease. Am J Respir Crit Care Med. 2020 04 15; 201(8):890-891. PMID: 31978312.

    Read at: PubMed

View 14 more publications: View full profile at BUMC

View all profiles